FDA Inspection
Laboratorios Grifols, S.A.Laboratorios Grifols, S.A. – FDA Inspection, Jul 26, 2024
Record Details
This FDA Inspection record concerns Laboratorios Grifols, S.A., with an inspection on July 26, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 7dd45d17-bc3d-4fa7-8139-3e5bbb5e474d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1244733
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
4- 21 CFR 211.188(b)Batch production and Batch Control Record Requirements
- 21 CFR 211.194(a)(4)Complete Test Data
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.67(b)Written procedures fail to include
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Laboratorios Grifols, S.A.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 19, 2026 | Not classified | Office of Inspections and Investigations | |
| October 27, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 20, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 8, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 21, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Laboratorios Grifols, S.A.
- FDA Inspection 1325702 - 2026-06-19
- FDA Inspection 1268869 - 2023-10-27
- FDA Inspection 1123400 - 2019-09-20
- FDA Inspection 1025750 - 2017-09-08
- FDA Inspection 931864 - 2015-05-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.